(Total Views: 535)
Posted On: 03/01/2021 4:16:02 PM
Post# of 72436
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
It was pointed out to me that Favipiravir is an anti-viral and that it has an 88% rate of efficacy but is only allowed in Japan and China. Just goes to show that B is the total package for both Efficacy AND Safety.
Read this on a board as to why Favi... not authorized in USA
"more to do with the side effect. it causes birth defects in pretty alarming rate.
Japanese government only allows it to be used as a backup, Chinese licensed the design but the government only allows it to be used when all other avenues are exhausted. "
Now my question is why it would even be used in Russia if Russia doesn't recognize it as an acceptable SOC? Don't think it would get much backing from the FDA with severe side effects listed above if they are true.
so the SOC only results may be higher in Russia than USA but if the SOC+B also raises the bar that would again look quite good for Brilacidin.
Read this on a board as to why Favi... not authorized in USA
"more to do with the side effect. it causes birth defects in pretty alarming rate.
Japanese government only allows it to be used as a backup, Chinese licensed the design but the government only allows it to be used when all other avenues are exhausted. "
Now my question is why it would even be used in Russia if Russia doesn't recognize it as an acceptable SOC? Don't think it would get much backing from the FDA with severe side effects listed above if they are true.
so the SOC only results may be higher in Russia than USA but if the SOC+B also raises the bar that would again look quite good for Brilacidin.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)